{"success":true,"data":{"pressRelease":{"id":"133137","rtpr_id":"nGNX4rwq00","ticker":"ANAB","exchange":"NASDAQ","all_tickers":["ANAB"],"title":"Anaptys Announces Participation at the H.C. Wainwright 28th Annual Global Investment Conference","author":"Globe Newswire","published_at":"2026-09-01T20:15:00.109Z","article_body":"SAN DIEGO, Sept. 01, 2026 (GLOBE NEWSWIRE) -- AnaptysBio, Inc. (Nasdaq: ANAB),\na company focused on managing the financial collaborations for Jemperli with\nGSK and imsidolimab with Vanda, today announced that Chris Murphy, chief\nfinancial officer, is scheduled to present at the H.C. Wainwright 28th Annual\nGlobal Investment Conference on Tuesday, Sept. 15, 2026. The presentation is\nscheduled to begin at 3:30pm ET.\n\nA live webcast of the presentation will be available on the investor section\nof the Anaptys website at https://ir.anaptysbio.com/presentations-and-events.\nA replay of the webcast will be available for at least 30 days following the\nevent.\n\nAbout Anaptys\n\nAnaptys manages the financial collaborations for Jemperli with GSK and\nimsidolimab with Vanda, with a focus on protecting and returning the value of\nits royalties to shareholders. To learn more, visit www.AnaptysBio.com or\nfollow us on LinkedIn\n(https://www.globenewswire.com/Tracker?data=J28ZOjEdE8YWEpFudgaemnL8ZoKZB2XhgfI3UFQqYbkiqI8WQE4vqeYWYziYp6uzCn--qseUo4zvTIv3c2DtJy-RgTZRsx2XjfDIaF6yhLE=).\n\nContact:\nChris Murphy\nChief Financial Officer\ninvestors@anaptysbio.com\n\n(https://www.globenewswire.com/NewsRoom/AttachmentNg/eb223f66-e7e0-4e0a-94e7-a3f7a06b13ab)\n\n\n\nGlobeNewswire, Inc. 2026","article_body_html":"","raw_payload":{"data":{"id":"nGNX4rwq00","title":"Anaptys Announces Participation at the H.C. Wainwright 28th Annual Global Investment Conference","author":"Globe Newswire","ticker":"ANAB","created":"2026-09-01T20:15:00.109Z","tickers":["ANAB"],"exchange":"NASDAQ","article_body":"SAN DIEGO, Sept. 01, 2026 (GLOBE NEWSWIRE) -- AnaptysBio, Inc. (Nasdaq: ANAB),\na company focused on managing the financial collaborations for Jemperli with\nGSK and imsidolimab with Vanda, today announced that Chris Murphy, chief\nfinancial officer, is scheduled to present at the H.C. Wainwright 28th Annual\nGlobal Investment Conference on Tuesday, Sept. 15, 2026. The presentation is\nscheduled to begin at 3:30pm ET.\n\nA live webcast of the presentation will be available on the investor section\nof the Anaptys website at https://ir.anaptysbio.com/presentations-and-events.\nA replay of the webcast will be available for at least 30 days following the\nevent.\n\nAbout Anaptys\n\nAnaptys manages the financial collaborations for Jemperli with GSK and\nimsidolimab with Vanda, with a focus on protecting and returning the value of\nits royalties to shareholders. To learn more, visit www.AnaptysBio.com or\nfollow us on LinkedIn\n(https://www.globenewswire.com/Tracker?data=J28ZOjEdE8YWEpFudgaemnL8ZoKZB2XhgfI3UFQqYbkiqI8WQE4vqeYWYziYp6uzCn--qseUo4zvTIv3c2DtJy-RgTZRsx2XjfDIaF6yhLE=).\n\nContact:\nChris Murphy\nChief Financial Officer\ninvestors@anaptysbio.com\n\n(https://www.globenewswire.com/NewsRoom/AttachmentNg/eb223f66-e7e0-4e0a-94e7-a3f7a06b13ab)\n\n\n\nGlobeNewswire, Inc. 2026"},"type":"article","timestamp":"2026-09-01T20:15:00.148073213Z","server_sent_at_ms":1788293700148},"received_at":"2026-09-01T20:15:00.234Z","source_url":"https://www.globenewswire.com/news-release/2026/09/01/3354606/0/en/anaptys-announces-participation-at-the-h-c-wainwright-28th-annual-global-investment-conference.html"},"analysis":{"id":"122028","press_release_id":"133137","analysis_json":{"industry":{"label":"Biotechnology","sector":"Health Care"},"redFlags":[],"eventType":"other","narrative":"AnaptysBio CFO Chris Murphy is scheduled to present at the H.C. Wainwright 28th Annual Global Investment Conference on September 15, 2026.\n\nThe presentation will be webcast live on the company's investor website, with a replay available for at least 30 days following the event.\n\nAnaptys manages financial collaborations for Jemperli with GSK and imsidolimab with Vanda.","sentiment":"neutral","agentHooks":{"shouldPost":false,"suggestedAngle":"Routine conference participation announcement."},"keyFigures":{},"quotedText":"","namedEntities":{"people":[{"name":"Chris Murphy","role":"CFO"}],"products":["Jemperli","imsidolimab"],"companies":[{"name":"AnaptysBio, Inc.","ticker":"ANAB"},{"name":"GSK","relationship":"partner"},{"name":"Vanda","relationship":"partner"},{"name":"H.C. Wainwright","relationship":"conference organizer"}],"dollarAmounts":[]},"materialImpact":{"score":1,"reasoning":"Routine announcement of participation in an investment conference with no material financial or operational updates disclosed."},"tickerRelevance":{"others":[],"primary":"ANAB"},"globalImportance":10,"audienceRelevance":15,"eventTypeSecondary":[],"importanceComponents":{"tickerTier":"small_cap","eventGravity":"routine_conference_participation","sectorWeight":"biotech"}},"event_type":"other","event_type_secondary":null,"sentiment":"neutral","material_impact_score":1,"narrative":"AnaptysBio CFO Chris Murphy is scheduled to present at the H.C. Wainwright 28th Annual Global Investment Conference on September 15, 2026.\n\nThe presentation will be webcast live on the company's investor website, with a replay available for at least 30 days following the event.\n\nAnaptys manages financial collaborations for Jemperli with GSK and imsidolimab with Vanda.","key_figures":{},"named_entities":{"people":[{"name":"Chris Murphy","role":"CFO"}],"products":["Jemperli","imsidolimab"],"companies":[{"name":"AnaptysBio, Inc.","ticker":"ANAB"},{"name":"GSK","relationship":"partner"},{"name":"Vanda","relationship":"partner"},{"name":"H.C. Wainwright","relationship":"conference organizer"}],"dollarAmounts":[]},"model_name":"glm-4.7","prompt_hash":"sha256:727b4b9429a443af","schema_hash":"sha256:05005c02d9cffac9","created_at":"2026-09-01T20:40:06.240Z","global_importance":10,"audience_relevance":15,"importance_components":{"tickerTier":"small_cap","eventGravity":"routine_conference_participation","sectorWeight":"biotech"}},"durationMs":208078,"modelName":"glm-4.7"}}